Oncology hospital-at-home with remote monitoring for toxicity
Manage fevers, dehydration and other treatment side-effects at home with visiting nurses, wearables and video, instead of admitting people to hospital wards.
Hospital-at-home programmes for medical conditions reduce cost and complications with equal or better outcomes. Oncology pilots (including for neutropenic fever in low-risk patients and post-chemotherapy support) show feasibility. The proposal is a scaled model combining patient-reported outcomes, wearable vital signs, home intravenous therapy and same-day nurse response, integrated with the oncology team, evaluated for safety and patient preference.
- Toxicity and quality of life are undervalued · Trials measure how long people live, not how they live. Side-effects are under-reported and under-treated.
- Fragmented care and guideline gaps · Patients fall between specialists, wait for referrals and often do not get the treatment guidelines say they should.
Pages like this
not linked directly; found by shared links- IdeaA standard handoff with medication reconciliation at every cancer care transition
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- IdeaWeekly electronic symptom reporting as a standard of care during systemic therapy
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- IdeaAcute oncology assessment units so sick cancer patients bypass the emergency department
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- IdeaHospital-at-home for oncology: treating low-risk febrile neutropenia and dehydration at home
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- Key paperBasch: asking patients to report symptoms online during chemotherapy improved survival
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- Key paperASCO 2021 guideline: how to recognise and manage the immune-related side effects of checkpoint inhibitors
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.
- CollectionESMO Clinical Practice Guidelines & MCBS
Shares Fragmented care and guideline gaps, Toxicity and quality of life are undervalued.